MedTrace Logo

Efficacy Evaluation of Avance QQ Collagen for Skin Beautification

NCT06771388 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-04-13

No results posted yet for this study

Summary

To assess Avance QQ Collagen product on skin condition improvement

Conditions

  • Skin Condition
  • Liposomal Encapsulation

Interventions

DIETARY_SUPPLEMENT

Liposomal collagen drink

consume 50 g liquid drink daily for 8 consecutive weeks

DIETARY_SUPPLEMENT

Non-liposomal collagen drink

consume 50 g liquid drink daily for 8 consecutive weeks

DIETARY_SUPPLEMENT

Placebo drink

consume 50 g liquid drink daily for 8 consecutive weeks

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chia-Hua Liang, Ph.D. · Chia Nan University of Pharmacy ＆ Science

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-01-24
Completion
2025-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06771388 on ClinicalTrials.gov